Landmark Trials To Know

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

IC2009B (Usewithcaution)

LandmarkTrials,ProminentPapers(shortlist) BART NEJMMay2008 Aprotinin=mortality,nephrotox. AlsomayAMI/CVA/thrombosis BAwareTrial TheLancet29May2004 2/3xequivocal=awareness BISdecreasesawarenessinhighriskgroups NNT=138x$16/BISuse=$2200/prevention BUnware NEJMMarch2008 BISvsETAG=nodiff Moreliberalinclusion(includingobesity,bblockers,extol) Singlehospitallikelyunderpowered CARP NEnglJMed2004Dec CoronaryarteryrevascPROPHYLAXIS(b4surgery) Nodiffb/wrevascandmedicalrxarmsforperiopeventsandEF@3mths NICESUGAR NEJMMarch2009 Prevevidence:hyperglycaemiaBSL>10mmol/L(180mg/dl)=worseM&Minacutelyill/ICU TightcontrolBSL[4.56]=death,hypoglycaemiacfaimingforBSL<10 ENIGMA Anesthesiology.107(2):221231,August2007. 80:O2/20:N2vs70:N2O/30:O2insurgery>2hrs...flawed SameLOS(primaryendpoint).complications(wound&atelectasis/pneumonia)&PONV ENIGMAII FiO20.3fixedthistime.N2OvsnoN2o Localstudy ISAT Lancet2002Oct Lowgradeaneurysmsforclipping.WFNSgrd13 Coiling:clipping=23:30%1yeardependency/death Possibletemporizingmeasureforhighgradeduetosurgicaldifficulties(oedema) IHASTI NEJM2005 Lowgradeaneurysmsforclipping.33Cvsnormothermia(36.5C) Nodiffneurooutcome(GlasgowOutcomeScore).Goodoutcomesin6065%ofbothgroups. Cooling=bacteraemia5vs2.5% Criticisms:notcoldenough,notearlyenough IMPACT NEJM2004 Ondansetron=dexamethadone=droperidol=TIVA.....(canPONV2530%) Patientsriskdeterminesmanagement MASTER AnesthesiaandAnalgesia2003;96(2):54854 EpivsIVopioids decreaseinlengthofventilatordependence o thereforenotofadvantageifpatientnotgoingtobereintubated undefinedpoints o whereinback,relativetoincision? o wasblockestablished? o whatwasinfusing? nowhaveketamineaswell qualityofanalgesiacanbeanendpoint

IC2009B (Usewithcaution)
MAGPIE Lancet2002 Mghalveseclampticrisk,probablyreducesmaternaldeath Mg>lyticcocktail(peth,chlorprom,promethazine)CochraneSystRev2001 DECREASEV JAmCollCardiol.2007May Coronaryrevascularizationprophylaxis(forsurgery)nobenefit CARPTRIAL NEnglJMed2004Dec Asabove REVERT Circulation.2007Jul3 BblockersslowcardiacremodellinginasympHF. COURAGETRIAL NEnglJMed.2007Apr PCIvsmaxmedicaltherapynosurvivalbenefits Confirmedin2009LancetmetaanalysisPTCA=BMS=DES=maxmed.Samesurvival. SAVE&TRACE&SMILEtrials ACEinhibpostAMIwilldelayonsetofHFsymptomsandmayimproveoutcome CAPRICORNTrial Lancet2001May5 BblockerpostAMI=deathAMI SOLVD NEnglJMed1992Sep AceinhibforasymptomaticHFsymptomsandAMI deathinfollowupXSOLVD PONVconsensusguidelinesAnaesthesiaandAnalgesia2003;97:6271 1.Identifyhighrisk o Ptfemale,nonsmoker,hxPONV/motionsickness (Apfel1999anaesthesiology10%baseline,then20%perRFincl.Opioids) o Anaesthopiods,N2O,volatiles o SurgENT,gynae,breast,eye,laparoscopy,neuro 2.Children o Studiesoftenrelatedtovomiting,notnausea o vomiting(cfadults),riskincreasestopuberty,m=ftillpuberty 3.Reducebaselinerisk(anaesthetictechnique) o Regional/tiva/O2/hydration o N2O/opiods/volatile/neostigmine 4.AppropriatePONVprophylaxis&TIMING o Anti5HT3endofsurgery.Droperidol=blackbox. o Prochlorperazine/Promethazineendofsurgery o Dexabeforeinduction(butuncomfortable),thereforeearlyaspossible o Nonpharmacupuncture/pressure/TENS/hypnosissomeefficacy o ControversialforPONVmaxolon,ginger,THC(goodforchemonauseatho) 5.ChildrenPONV o Gran40mcg/kg,ond0.1mg/kg,drop0.05mg/kg,dexa0.15mg/kg 6.Monotherapyinferiortocombo(prophylaxisANDrescue) Pressorsinobstetrics(CurrentOpinioninAnaesthesiology:June2006) Alphaagonists>ephedrine:nausea,FHRchanges,bettercontrol ATACAS expectpublication20112012(5yrtrial,beginning2006) AspiringandtranexamicacidinCAGS CEA NASCET(Stroke1991Jun) o Symptomaticptswithipsilateral:CEAvsmedical o 30days:morestrokedeathinCEAgroup(5.8%vs3.3%)

IC2009B (Usewithcaution)
o 2yrcumulativerisklowerlessipsilateralstroke/death(DELAYEDbenefit) o Morebenefitinage>75 ECST(Lancet1991May) o Symptomatic:Medicaltherapy(aspirin)vsCEA o Forcontrolgrp(medrx):riskofstrokerelatedtostenosisseverityONLYfor1st23yrs o GenerallyconfirmedNASCET ACAS(JAMA1995)/ACST(Lancet2004May o CEAbetter2yroutcomeforipsilateralstroke/death(5%vs11%) o Lessbenefitthansymptomatic(recommend:needlowersurgicalrisk<3%vs<6%) o Delaytobenefit/longterminvestment(worseoutcomeinsurgicalgroupforsometime o Evidencelesscompellingforwomen GALA(Lancet2008:372pg21322142) o NodiffbetweenGAvsLAat30daysforstroke/AMI/death

Bblockers AtenololstudyMangano,etal.(NEnglJMed1996) o Increasedsurvivalwithatenolol BisoprololstudyPoldermans,etal.(NEnglJMed1999) o 91%reductioninperiopAMI POISETrialLancet.2008May o Aggressivemetoprolol(delay/withholddrugsonlyifHR<50orSBP<100) o Bblockers=moredeath,morestroke,lessAMI ATRIAtrial CHADS2scorederivedfromthis. Otherpublications AnaesthesiaandIntensiveCare2009 TheREASONAudit ANZCATrialsGroup&ANZCAPerioperativeMedicineCommittee(localaudit) POMscore o Preandpostoppredictors o 3xA:age,ASA,albumin o 3xI:unintendedICU,inflammation,acuterenalimpairment

You might also like